Assignee
AMUNIX PHARMACEUTICALS INC
US·9 granted patents·23 pending applications·19 citations·filing 2016–2025
Top patents by PatentIndex Score
32 records- 0196US10961287B2Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·10 cites·19 claims
- 0293US10870874B2Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2018·Granted Dec 22, 2020·5 cites·19 claims
- 0389US11713358B2Chimeric polypeptide assembly and methods of making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2023·4 cites·72 claims
- 0489US2025051405A1Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0582US2024067695A1Glucagon-like peptide-2 compositions and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0682US2024279354A1Chimeric polypeptide assembly and methods of making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0780US11981744B2Chimeric polypeptide assembly and methods of making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Granted May 14, 2024·0 cites·10 claims
- 0880US2025197912A1Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0979US2024018260A1Chimeric polypeptide assembly and methods of making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1078US2024091315A1Xten conjugate compositions and methods of making sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1177US12215156B2HER-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 1276US12071456B2Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2021·Granted Aug 27, 2024·0 cites·7 claims
- 1372US2021164011A1Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1472US2025163153A1Release segments and binding compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1572US2026055205A1Compositions targeting prostate-specific membrane antigen (psma) and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1671US12428494B2Compositions targeting prostate-specific membrane antigen and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2025·Granted Sep 30, 2025·0 cites·8 claims
- 1771US2024327538A1Compositions targeting prostate-specific membrane antigen and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1871US2025388643A1Glucagon-like peptide-2 compositions and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1968US2021322518A1Xten conjugate compositions and methods of making sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2067US2023061715A1Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2165US12590159B2Compositions targeting epidermal growth factor receptor and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2025·Granted Mar 31, 2026·0 cites·8 claims
- 2265US2020392195A1Glucagon-like peptide-2 compositions and methods of making and using sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2364US2024400696A1Compositions targeting epidermal growth factor receptor and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2462US2023322922A1Her-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2561US12060424B2Release segments and binding compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2018·Granted Aug 13, 2024·0 cites·20 claims
- 2658US2023265146A1Cytokine conjugatesAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2751US2021054077A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2851US2023121775A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2950US2023324389A1Compositions and methods related to activatable therapeutic agentsAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3047US2023287040A1Barcoded xten polypeptides and compositions thereof, and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3144US2023312729A1Egfr antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3236US2020000884A1Treatment of adult growth hormone deficiency with human growth hormone analoguesAMUNIX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →